Latest News

• share
• favorite_border

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic mutation causing it. Some patients even experienced a 10,000-fold improvement in their vision after receiving the highest dose of the therapy, according to researchers from the Perelman School of Medicine at the University of Pennsylvania who co-led the clinical trial published in The Lancet.

• share
• favorite_border

A new tool for monitoring immune health patterns over time reveals how a pair of checkpoint inhibitor therapies works together to recruit new cancer-fighting T cells with every infusion.

• share
• favorite_border

The small but dedicated Hospital Emergency Response Team works year-round to imagine and prepare for major crises that could disrupt patient care.

• share
• favorite_border

Predicting a patient’s recovery from a coma has profound implications. Neurologist David Fischer, MD, is building the infrastructure to get it right.

• share
• favorite_border

The University of Pennsylvania and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their collaboration to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center (ACC).

• share
• favorite_border

• share
• favorite_border

A large trial of strategies to reduce distracted driving showed that those that were “gamified” yielded a lasting reduction in handheld phone usage while driving

• share
• favorite_border

There are many important reasons for keeping cuts and sores clean, but new research from the Perelman School of Medicine at the University of Pennsylvania shows that a certain can facilitate healing of hard-to-treat wounds among people with diabetes.

• share
• favorite_border

The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on the surface of T cells, according to a preclinical study from investigators at the University of Pennsylvania’s Perelman School of Medicine and Abramson Cancer Center.

• share
• favorite_border

Researchers discovered that feedback plus cash incentives designed with insights from behavioral science reduces phone use while driving

• share
• favorite_border

A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation (aiTBS). While current theta burst stimulation (TBS) treatments can take between four and six weeks to administer, this new technique reduces treatment to five days.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

An international team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke (NINDS).

• share
• favorite_border

• share
• favorite_border

High response rates for patients with stage 4 lung cancer after anti-inflammatory drug added temporarily to immune checkpoint inhibitor therapy